These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18284101)

  • 41. Mediators of interpersonal violence and drug addiction severity among methamphetamine users in Cape Town, South Africa.
    Hobkirk AL; Watt MH; Green KT; Beckham JC; Skinner D; Meade CS
    Addict Behav; 2015 Mar; 42():167-71. PubMed ID: 25479528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men.
    Halkitis PN; Parsons JT; Stirratt MJ
    J Homosex; 2001; 41(2):17-35. PubMed ID: 11482426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.
    Cunningham JK; Liu LM; Callaghan RC
    Addiction; 2016 Nov; 111(11):1999-2009. PubMed ID: 27529812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
    Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
    Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users.
    Semple SJ; Zians J; Strathdee SA; Patterson TL
    J Psychoactive Drugs; 2007 Nov; Suppl 4():353-66. PubMed ID: 18284102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will.
    Worth H; Rawstorne P
    Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470
    [No Abstract]   [Full Text] [Related]  

  • 51. Crystal methamphetamine: a source of added sexual risk for Hispanic men who have sex with men?
    Fernández MI; Bowen GS; Warren JC; Ibañez GE; Hernandez N; Harper GW; Prado G
    Drug Alcohol Depend; 2007 Jan; 86(2-3):245-52. PubMed ID: 16930858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.
    Rungnirundorn T; Verachai V; Gelernter J; Malison RT; Kalayasiri R
    J Addict Med; 2017; 11(1):19-27. PubMed ID: 27649265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
    Kay-Lambkin FJ
    Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and profile of methamphetamine users in adolescents at a juvenile classification home.
    Miura H; Fujiki M; Shibata A; Ishikawa K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):352-7. PubMed ID: 16732753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality, causes of death, and health status among methamphetamine users.
    Herbeck DM; Brecht ML; Lovinger K
    J Addict Dis; 2015; 34(1):88-100. PubMed ID: 25415384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring the prevalence and correlates of methamphetamine use: findings from Sacramento's ADAM program.
    Yacoubian GS; Peters RJ
    J Drug Educ; 2004; 34(3):281-94. PubMed ID: 15648888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A qualitative exploration of perceived gender differences in methamphetamine use among women who use methamphetamine on the Mexico-U.S. border.
    Loza O; Ramos R; Ferreira-Pinto J; Hernandez MT; Villalobos SA
    J Ethn Subst Abuse; 2016; 15(4):405-424. PubMed ID: 26689233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.